Home LiteratureArticle Details
PMID: 20005808 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Reduced IGF-1 signaling delays age-associated proteotoxicity in mice.

Cell ·Vol. 139 ·No. 6 ·2009-12-11 ·Pages 1157-69

Cohen E, Paulsson JF, Blinder P, Burstyn-Cohen T, Du D, Estepa G, Adame A, Pham HM, Holzenberger M, Kelly JW, Masliah E, Dillin A

Abstract

The insulin/insulin growth factor (IGF) signaling (IIS) pathway is a key regulator of aging of worms, flies, mice, and likely humans. Delayed aging by IIS reduction protects the nematode C. elegans from toxicity associated with the aggregation of the Alzheimer's disease-linked human peptide, Abeta. We reduced IGF signaling in Alzheimer's model mice and discovered that these animals are protected from Alzheimer's-like disease symptoms, including reduced behavioral impairment, neuroinflammation, and neuronal loss. This protection is correlated with the hyperaggregation of Abeta leading to tightly packed, ordered plaques, suggesting that one aspect of the protection conferred by reduced IGF signaling is the sequestration of soluble Abeta oligomers into dense aggregates of lower toxicity. These findings indicate that the IGF signaling-regulated mechanism that protects from Abeta toxicity is conserved from worms to mammals and point to the modulation of this signaling pathway as a promising strategy for the development of Alzheimer's disease therapy.

MeSH Terms
Alzheimer Disease/metabolism,physiopathology Amyloid beta-Peptides/metabolism Animals Humans Insulin-Like Growth Factor I/metabolism Longevity Male Mice Mice, Transgenic Presenilin-1/genetics,metabolism Receptor, IGF Type 1/metabolism Signal Transduction
Chemicals
Amyloid beta-Peptides PSEN1 protein, human Presenilin-1 Insulin-Like Growth Factor I Receptor, IGF Type 1
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Cohen Ehud
Howard Hughes Medical Institute, Glenn Center for Aging Research, Molecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Paulsson Johan F
Blinder Pablo
Burstyn-Cohen Tal
Du Deguo
Estepa Gabriela
Adame Anthony
Pham Hang M
Holzenberger Martin
Kelly Jeffery W
Masliah Eliezer
Dillin Andrew
References (57)
57 references, click to expand
  1. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging.
    Neuroscience. 2005;130(3):667-84 PMID: 15590151
  2. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging.
    Cell. 2008 Nov 28;135(5):907-18 PMID: 19041753
  3. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1.
    Science. 2009 Feb 20;323(5917):1063-6 PMID: 19229036
  4. Alzheimer disease: mechanistic understanding predicts novel therapies.
    Ann Intern Med. 2004 Apr 20;140(8):627-38 PMID: 15096334
  5. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span.
    Cell. 2006 Jun 2;125(5):987-1001 PMID: 16751106
  6. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers.
    Science. 2004 Jun 18;304(5678):1793-7 PMID: 15155912
  7. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?
    Neurobiol Aging. 2006 Nov;27(11):1618-31 PMID: 16274856
  8. IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP.
    Neurobiol Aging. 2009 Dec;30(12):2021-30 PMID: 18394756
  9. Forkhead transcription factors and ageing.
    Oncogene. 2008 Apr 7;27(16):2351-63 PMID: 18391977
  10. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.
    Nature. 1999 Apr 8;398(6727):513-7 PMID: 10206644
  11. Heat shock response modulators as therapeutic tools for diseases of protein conformation.
    J Biol Chem. 2005 Sep 30;280(39):33097-100 PMID: 16076838
  12. Extension of murine life span by overexpression of catalase targeted to mitochondria.
    Science. 2005 Jun 24;308(5730):1909-11 PMID: 15879174
  13. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.
    J Neurosci. 2002 Mar 1;22(5):1858-67 PMID: 11880515
  14. Synaptic loss in Alzheimer's disease and other dementias.
    Neurology. 1989 Mar;39(3):355-61 PMID: 2927643
  15. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans.
    Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10417-22 PMID: 12122205
  16. Functionally significant insulin-like growth factor I receptor mutations in centenarians.
    Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3438-42 PMID: 18316725
  17. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers.
    Mol Cell. 2006 Sep 15;23(6):887-97 PMID: 16973440
  18. Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14163-8 PMID: 17715058
  19. Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy.
    J Neurochem. 2006 Aug;98(4):1032-45 PMID: 16895578
  20. Serum insulin-like growth factor I regulates brain amyloid-beta levels.
    Nat Med. 2002 Dec;8(12):1390-7 PMID: 12415260
  21. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
    Neurobiol Aging. 2010 May;31(5):747-57 PMID: 18657882
  22. Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection.
    J Biol Chem. 2002 Sep 6;277(36):32985-91 PMID: 12095987
  23. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.
    Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9368-72 PMID: 7568134
  24. Brain IRS2 signaling coordinates life span and nutrient homeostasis.
    Science. 2007 Jul 20;317(5836):369-72 PMID: 17641201
  25. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.
    Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9712-7 PMID: 10931940
  26. Quantitative assessment of cortical synaptic density in Alzheimer's disease.
    Neurobiol Aging. 1990 Jan-Feb;11(1):29-37 PMID: 2325814
  27. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.
    Genes Brain Behav. 2007 Feb;6(1):54-65 PMID: 17233641
  28. Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type.
    Acta Neuropathol. 1983;61(1):76-80 PMID: 6353837
  29. Molecular pathways to neurodegeneration.
    Nat Med. 2004 Jul;10 Suppl:S2-9 PMID: 15272266
  30. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
    Nat Med. 2008 Aug;14(8):837-42 PMID: 18568035
  31. Association of FOXO3A variation with human longevity confirmed in German centenarians.
    Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2700-5 PMID: 19196970
  32. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months.
    Physiol Behav. 2002 Apr 15;75(5):627-42 PMID: 12020728
  33. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.
    Annu Rev Neurosci. 2003;26:267-98 PMID: 12704221
  34. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice.
    Nature. 2003 Jan 9;421(6919):182-7 PMID: 12483226
  35. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.
    Neurology. 1998 Jan;50(1):164-8 PMID: 9443474
  36. Insulin-like signaling, nutrient homeostasis, and life span.
    Annu Rev Physiol. 2008;70:191-212 PMID: 17988211
  37. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.
    Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12 PMID: 17245412
  38. Potential roles of insulin and IGF-1 in Alzheimer's disease.
    Trends Neurosci. 2003 Aug;26(8):404-6 PMID: 12900169
  39. A C. elegans mutant that lives twice as long as wild type.
    Nature. 1993 Dec 2;366(6454):461-4 PMID: 8247153
  40. The anti-aging, metabolism potential of SIRT1.
    Curr Opin Investig Drugs. 2008 Oct;9(10):1095-102 PMID: 18821472
  41. Extended longevity in mice lacking the insulin receptor in adipose tissue.
    Science. 2003 Jan 24;299(5606):572-4 PMID: 12543978
  42. A specific amyloid-beta protein assembly in the brain impairs memory.
    Nature. 2006 Mar 16;440(7082):352-7 PMID: 16541076
  43. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function.
    Science. 2001 Apr 6;292(5514):107-10 PMID: 11292875
  44. Genetically altered transgenic models of Alzheimer's disease.
    J Neural Transm Suppl. 2000;59:175-83 PMID: 10961430
  45. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.
    Biomol Eng. 2001 Jun;17(6):157-65 PMID: 11337275
  46. Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease.
    J Neurosci. 2009 Jul 8;29(27):8805-15 PMID: 19587288
  47. FOXO3A genotype is strongly associated with human longevity.
    Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13987-92 PMID: 18765803
  48. The insulin paradox: aging, proteotoxicity and neurodegeneration.
    Nat Rev Neurosci. 2008 Oct;9(10):759-67 PMID: 18769445
  49. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.
    Biochem Biophys Res Commun. 1984 May 16;120(3):885-90 PMID: 6375662
  50. Opposing activities protect against age-onset proteotoxicity.
    Science. 2006 Sep 15;313(5793):1604-10 PMID: 16902091
  51. Impairment of spatial memory consolidation in APP(751SL) mice results in cue-guided response.
    Neurobiol Aging. 2008 Jul;29(7):1011-21 PMID: 17350733
  52. Aging as a major risk for degenerative diseases of the central nervous system.
    Curr Opin Neurol. 1994 Aug;7(4):283-6 PMID: 7952234
  53. Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.
    J Biol Chem. 2007 Aug 17;282(33):23818-28 PMID: 17548355
  54. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.
    Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10417-22 PMID: 12925731
  55. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans.
    Science. 1997 Aug 15;277(5328):942-6 PMID: 9252323
  56. Modulation of neurodegeneration by molecular chaperones.
    Nat Rev Neurosci. 2005 Jan;6(1):11-22 PMID: 15611723
  57. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.
    Hum Mol Genet. 2004 Jan 15;13(2):159-70 PMID: 14645205
Article Info
Journal
Cell
Abbr.
Cell
ISSN
1097-4172
Published
2009-12-11
Pages
1157-69
Language
English
Region
United States
NLM ID
0413066
PMCID
PMC3017511
Subset
IM
Grants
NIA NIH HHS · P01 AG031097 · United States
NIA NIH HHS · P01 AG031097-01A18147 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]